357 related articles for article (PubMed ID: 28797715)
1. Universal Point of Care Testing for Lynch Syndrome in Patients with Upper Tract Urothelial Carcinoma.
Metcalfe MJ; Petros FG; Rao P; Mork ME; Xiao L; Broaddus RR; Matin SF
J Urol; 2018 Jan; 199(1):60-65. PubMed ID: 28797715
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of Lynch syndrome among patients with upper urinary tract carcinoma in a Japanese hospital-based population.
Ito T; Kono K; Eguchi H; Okazaki Y; Yamamoto G; Tachikawa T; Akagi K; Okada Y; Kawakami S; Morozumi M; Tamaru JI; Ishida H
Jpn J Clin Oncol; 2020 Jan; 50(1):80-88. PubMed ID: 31665498
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological characteristics of patients with upper urinary tract urothelial cancer with loss of immunohistochemical expression of the DNA mismatch repair proteins in universal screening.
Urakami S; Inoshita N; Oka S; Miyama Y; Nomura S; Arai M; Sakaguchi K; Kurosawa K; Okaneya T
Int J Urol; 2018 Feb; 25(2):151-156. PubMed ID: 29164703
[TBL] [Abstract][Full Text] [Related]
4. Upper tract urothelial carcinomas: frequency of association with mismatch repair protein loss and lynch syndrome.
Harper HL; McKenney JK; Heald B; Stephenson A; Campbell SC; Plesec T; Magi-Galluzzi C
Mod Pathol; 2017 Jan; 30(1):146-156. PubMed ID: 27713421
[TBL] [Abstract][Full Text] [Related]
5. Lynch Syndrome: A Primer for Urologists and Panel Recommendations.
Mork M; Hubosky SG; Rouprêt M; Margulis V; Raman J; Lotan Y; O'Brien T; You N; Shariat SF; Matin SF
J Urol; 2015 Jul; 194(1):21-9. PubMed ID: 25711197
[TBL] [Abstract][Full Text] [Related]
6. Lynch syndrome in upper tract urothelial carcinoma: significance, screening, and surveillance.
Pradere B; Lotan Y; Roupret M
Curr Opin Urol; 2017 Jan; 27(1):48-55. PubMed ID: 27533503
[TBL] [Abstract][Full Text] [Related]
7. Molecular subtype classification of urothelial carcinoma in Lynch syndrome.
Therkildsen C; Eriksson P; Höglund M; Jönsson M; Sjödahl G; Nilbert M; Liedberg F
Mol Oncol; 2018 Aug; 12(8):1286-1295. PubMed ID: 29791078
[TBL] [Abstract][Full Text] [Related]
8. Upper tract urothelial carcinoma: a clinicopathologic study including microsatellite instability analysis.
Blaszyk H; Wang L; Dietmaier W; Hofstädter F; Burgart LJ; Cheville JC; Hartmann A
Mod Pathol; 2002 Aug; 15(8):790-7. PubMed ID: 12181263
[TBL] [Abstract][Full Text] [Related]
9. Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum.
Rouprêt M; Yates DR; Comperat E; Cussenot O
Eur Urol; 2008 Dec; 54(6):1226-36. PubMed ID: 18715695
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and characteristics of patients with upper urinary tract urothelial carcinoma having potential Lynch syndrome identified by immunohistochemical universal screening and Amsterdam criteria II.
Tanabe K; Nakanishi Y; Okubo N; Matsumoto S; Umino Y; Kataoka M; Yajima S; Yoshida T; Miyazaki S; Kuwata T; Ishii G; Watanabe R; Masuda H
BMC Cancer; 2023 Oct; 23(1):940. PubMed ID: 37798659
[TBL] [Abstract][Full Text] [Related]
11. Hereditary non-polyposis colorectal cancer/Lynch syndrome in three dimensions.
Kravochuck SE; Church JM
ANZ J Surg; 2017 Dec; 87(12):1006-1010. PubMed ID: 26990828
[TBL] [Abstract][Full Text] [Related]
12. Urinary Tract Cancer in Lynch Syndrome; Increased Risk in Carriers of MSH2 Mutations.
Joost P; Therkildsen C; Dominguez-Valentin M; Jönsson M; Nilbert M
Urology; 2015 Dec; 86(6):1212-7. PubMed ID: 26385421
[TBL] [Abstract][Full Text] [Related]
13. [Should we systematically screen for Lynch syndrome in patients with upper urinary tract carcinoma?].
Olagui GS; Pignot G; Rouquette A; Vieillefond A; Amsellem-Ouazana D; de Longchamps NB; Radenen B; Zerbib M; Terris B
Bull Cancer; 2014 Feb; 101(2):144-50. PubMed ID: 24556207
[TBL] [Abstract][Full Text] [Related]
14. Population-based molecular screening for Lynch syndrome: implications for personalized medicine.
Ward RL; Hicks S; Hawkins NJ
J Clin Oncol; 2013 Jul; 31(20):2554-62. PubMed ID: 23733757
[TBL] [Abstract][Full Text] [Related]
15. Simplified identification of Lynch syndrome: a prospective, multicenter study.
Bonnet D; Selves J; Toulas C; Danjoux M; Duffas JP; Portier G; Kirzin S; Ghouti L; Carrère N; Suc B; Alric L; Barange K; Buscail L; Chaubard T; Imani K; Guimbaud R
Dig Liver Dis; 2012 Jun; 44(6):515-22. PubMed ID: 22480969
[TBL] [Abstract][Full Text] [Related]
16. Universal Versus Targeted Screening for Lynch Syndrome: Comparing Ascertainment and Costs Based on Clinical Experience.
Erten MZ; Fernandez LP; Ng HK; McKinnon WC; Heald B; Koliba CJ; Greenblatt MS
Dig Dis Sci; 2016 Oct; 61(10):2887-2895. PubMed ID: 27384051
[TBL] [Abstract][Full Text] [Related]
17. Editorial comment on: upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch syndrome) tumor spectrum.
Mongiat-Artus P
Eur Urol; 2008 Dec; 54(6):1235-6. PubMed ID: 18715693
[No Abstract] [Full Text] [Related]
18. Lynch syndrome in urological practice: diagnosis, therapeutic strategies, and screening for upper tract urothelial carcinoma.
Lonati C; Moschini M; Simeone C; Spiess PE; Necchi A
Curr Opin Urol; 2022 Jan; 32(1):40-47. PubMed ID: 34608026
[TBL] [Abstract][Full Text] [Related]
19. Utility of immunohistochemistry for mismatch repair proteins on colorectal polyps in the familial cancer clinic.
Dow E; Buchanan DD; Winship IM
Intern Med J; 2018 Nov; 48(11):1325-1330. PubMed ID: 29717530
[TBL] [Abstract][Full Text] [Related]
20. Targeted Cancer Next-Generation Sequencing as a Primary Screening Tool for Microsatellite Instability and Lynch Syndrome in Upper Gastrointestinal Tract Cancers.
Christakis AG; Papke DJ; Nowak JA; Yurgelun MB; Agoston AT; Lindeman NI; MacConaill LE; Sholl LM; Dong F
Cancer Epidemiol Biomarkers Prev; 2019 Jul; 28(7):1246-1251. PubMed ID: 31028081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
